CARBONI, EZIO
 Distribuzione geografica
Continente #
EU - Europa 160.429
NA - Nord America 9.113
AS - Asia 3.835
SA - Sud America 641
AF - Africa 88
OC - Oceania 30
Continente sconosciuto - Info sul continente non disponibili 9
Totale 174.145
Nazione #
IT - Italia 157.700
US - Stati Uniti d'America 8.979
CN - Cina 1.454
SG - Singapore 1.428
UA - Ucraina 732
DE - Germania 544
BR - Brasile 517
SE - Svezia 439
FI - Finlandia 312
VN - Vietnam 271
GB - Regno Unito 237
FR - Francia 208
HK - Hong Kong 151
KR - Corea 100
IN - India 79
RU - Federazione Russa 79
CA - Canada 76
BD - Bangladesh 54
JP - Giappone 52
AR - Argentina 51
NL - Olanda 44
MX - Messico 36
TR - Turchia 29
IE - Irlanda 25
AU - Australia 24
IQ - Iraq 23
PL - Polonia 22
CL - Cile 20
PK - Pakistan 20
ES - Italia 19
ZA - Sudafrica 18
IR - Iran 17
UZ - Uzbekistan 16
ID - Indonesia 15
TH - Thailandia 15
CO - Colombia 14
EG - Egitto 13
IL - Israele 13
MA - Marocco 13
PH - Filippine 13
AT - Austria 12
BE - Belgio 12
EC - Ecuador 11
VE - Venezuela 11
SA - Arabia Saudita 10
EU - Europa 9
GH - Ghana 9
KE - Kenya 9
MY - Malesia 9
CY - Cipro 8
OM - Oman 8
CZ - Repubblica Ceca 7
BO - Bolivia 6
LB - Libano 6
NP - Nepal 6
NZ - Nuova Zelanda 6
TW - Taiwan 6
AE - Emirati Arabi Uniti 5
AZ - Azerbaigian 5
GR - Grecia 5
JO - Giordania 5
KZ - Kazakistan 5
TN - Tunisia 5
TT - Trinidad e Tobago 5
UY - Uruguay 5
DZ - Algeria 4
ET - Etiopia 4
JM - Giamaica 4
LT - Lituania 4
PY - Paraguay 4
RO - Romania 4
AL - Albania 3
CH - Svizzera 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
KW - Kuwait 3
MU - Mauritius 3
PA - Panama 3
BY - Bielorussia 2
CI - Costa d'Avorio 2
HN - Honduras 2
HU - Ungheria 2
LU - Lussemburgo 2
MK - Macedonia 2
PE - Perù 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BW - Botswana 1
CG - Congo 1
DK - Danimarca 1
GA - Gabon 1
GN - Guinea 1
HR - Croazia 1
KG - Kirghizistan 1
KH - Cambogia 1
LK - Sri Lanka 1
LV - Lettonia 1
Totale 174.133
Città #
Cagliari 154.074
Uta 3.203
Fairfield 878
Woodbridge 871
Singapore 718
Ashburn 659
Chandler 565
San Jose 493
Houston 484
Boardman 407
Ann Arbor 404
Jacksonville 404
Wilmington 390
Seattle 379
Dallas 335
Nyköping 280
Cambridge 277
Dearborn 252
Beijing 223
Helsinki 188
Los Angeles 143
Hefei 126
Nanjing 119
Hong Kong 114
Santa Clara 105
Lauterbourg 104
Boston 100
The Dalles 100
Ho Chi Minh City 88
Shanghai 87
Seoul 86
Guangzhou 74
Hanoi 66
Buffalo 63
New York 63
San Diego 47
Milan 45
Shenyang 45
Redwood City 40
São Paulo 39
Hebei 38
Council Bluffs 37
Toronto 37
Frankfurt am Main 32
Nanchang 32
Tokyo 32
Jiaxing 29
Orem 29
Mountain View 28
Tianjin 27
Jinan 25
Changsha 24
Munich 22
Amsterdam 21
Atlanta 21
Dublin 21
Norwalk 21
Zhengzhou 19
London 18
Verona 18
Redondo Beach 17
San Francisco 17
Assèmini 16
Brooklyn 15
Dhaka 15
Tashkent 15
Washington 15
Chicago 14
Da Nang 14
Montreal 14
Orange 14
Turku 14
Auburn Hills 13
San Mateo 13
Augusta 12
Brussels 12
Rio de Janeiro 12
Belo Horizonte 11
Ningbo 11
Pune 11
Warsaw 11
Haiphong 10
Kunming 10
Wuhan 10
Accra 9
Chennai 9
Denver 9
Rome 9
Columbus 8
Detroit 8
Guarulhos 8
Indiana 8
Johannesburg 8
Karachi 8
Manchester 8
Mexico City 8
Mumbai 8
Nicosia 8
Nuremberg 8
Saint Petersburg 8
Totale 168.117
Nome #
Key role of salsolinol in ethanol actions on dopamine neuronal activity of the posterior ventral tegmental area 5.424
Differential sensitivity of ethanol-elicited ERK phosphorylation in nucleus accumbens of Sardinian alcohol-preferring and -non preferring rats 4.165
null 4.110
Immunization with DISC1 protein in an animal model of ADHD influences behavior and excitatory amino acids in prefrontal cortex and striatum 3.642
The MPTP/probenecid model of progressive Parkinson's disease 3.512
Increase of dopamine and norepinephrine release in the bed nucleus of stria terminalis: a common feature of antidepressants? 3.499
Immunomodulatory drugs alleviate l-dopa-induced dyskinesia in a rat model of Parkinson's disease 3.460
Rosiglitazone decreases peroxisome proliferator receptor-gamma levels in microglia and inhibits TNF-alpha production: new evidences on neuroprotection in a progressive Parkinson's disease model. 3.251
PPAR-gamma agonist rosiglitazone inhibits TNF-alpha production by microglia and arrests nigrostriatal degeneration in a progressive Parkinson’s disease model. 3.163
A442 PPAR-gamma agonist rosiglitazone inhibits TNF-alpha production by microglia and arrests neurodegeneration in a progressive Parkinson´s disease model 3.011
Do PPAR-Gamma Agonists Have a Future in Parkinson's Disease Therapy? 2.853
PRENATAL RESTRAINT STRESS: AN IN VIVO MICRODIALYSIS STUDY ON CATECHOLAMINE RELEASE IN THE RAT PREFRONTAL CORTEX 2.816
52) Carboni E., Ibba M., Schirru C., Sadile A. (2009). BEHAVIORAL AND NEUROCHEMICAL CHANGES INDUCED BY METHYLPHENIDATE OR ATOMOXETINE SUB-CHRONIC TREATMENT IN ADOLESCENT SPONTANEOUS HYPERTENSIVE RATS (SHR) ARE GENDER SPECIFIC 2.718
Long term effects of adolescent chronic mild stress on brain catecholamine transmission in rat brain: a microdialysis study 2.645
null 2.592
Antidepressants share the ability to increase catecholamine output in the bed nucleus of stria terminalis: a possible role in antidepressant therapy? 2.586
The alpha 7 nicotinic acetylcholine receptor (nAChR) allosteric modulator UCI-40083 differentially increases dopamine (DA) and norepinephrine (NE) release in adolescent rat brain 2.545
Prepuberal Stimulation of 5-HT7-R by LP-211 in a Rat Model of Hyper-Activity and Attention-Deficit: Permanent Effects on Attention, Brain Amino Acids and Synaptic Markers in the Fronto-Striatal Interface 2.545
Different classes of antidepressants increase dopamine and norepinephrine release in the bed nucleus of stria terminalis: an “in vivo” microdialysis study 2.538
Disease modifying treatment with PPAR-gamma agonist rosiglitazone in a progressive mouse model of Parkinson's disease 2.489
The α7 nicotinic acetylcholine receptor (nAChR) allosteric modulator UCI-40083 differentially increases dopamine (DA) and norepinephrine (NE) release in adolescent rat brain 2.462
Progressive Dopaminergic Degeneration in the Chronic MPTPp Mouse Model of Parkinson's Disease 2.421
Nicotine, cocaine, amphetamine, morphine, and ethanol increase norepinephrine output in the bed nucleus of stria terminalis of freely moving rats 2.283
Ketamine modulates catecholamine transmission in the bed nucleus of stria terminalis: The possible role of this region in the antidepressant effects of ketamine 2.240
PPAR-gamma-mediated neuroprotection in a chronic mouse model of Parkinson's disease 2.235
Different classes of antidepressants share the ability to increase dopamine and norepinephrine release in the bed nucleus of stria terminalis: A possible role in antidepressant therapy? 2.166
null 2.160
PPAR-GAMMA RECEPTOR AGONIST PREVENTS NEURODEGENERATION AND BEHAVIOURAL DEFICITS IN A CHRONIC MPTP MOUSE MODEL OF PARKINSON’S DISEASE. 2.091
Chronic methylphenidate or atomoxetine treatment alters BDNF expression in the brain of spontaneously hypertensive rats 2.090
Drug induced release of dopamine and noradrenaline in the forebrain of the prenatally stressed rats 2.015
The interrelationship between dopamine and noradrenaline in the prefrontal cortex: From physiology to therapy 1.995
(D-Ala2)deltorphin II: D1-dependent stereotypies and stimulation of dopamine release in the nucleus accumbens 1.992
PROGRESSIVE DECLINE OF BEHAVIORAL AND BIOCHEMICAL PARAMETERS IN THE CHRONIC MPTP/PROBENECID MOUSE MODEL OF PARKINSON’S DISEASE. 1.945
PEROXIZOME-PROLIFERATOR ACTIVATED RECEPTOR GAMMA (PPARG) AGONIST ROSIGLITAZONE COUNTERACTS BEHAVIORAL AND BIOCHEMICAL DEFICITS IN A CHRONIC 1-METHYL-4-PHENIL-1,2,3,4 TETRAHYDROPYRIDINE (MPTP) MOUSE MODEL OF PARKINSON’S DISEASE 1.867
METHYLPHENIDATE AND ATOMOXETINE AFFECT BDNF EXPRESSION IN THE BRAIN OF SPONTANEOUS HYPERTENSIVE RATS. 1.863
Sub-chronic exposure to atomoxetine up-regulates BDNF expression and signalling in the brain of adolescent spontaneously hypertensive rats: comparison with methylphenidate. 1.784
Advances in modelling alpha-synuclein-induced Parkinson's diseases in rodents: virus-based models versus inoculation of exogenous preformed toxic species 1.777
Enhanced limbic/impaired cortical-loop connection onto the hippocampus of NHE rats: Application of resting-state functional connectivity in a preclinical ADHD model 1.764
Effects of sub-chronic methylphenidate and atomoxetine on noradrenaline and dopamine transmission in the prefrontal cortex of adolescent SH rats, an animal model of ADHD 1.719
Prepuberal subchronic methylphenidate and atomoxetine induce different long-term effects on adult behaviour and forebrain dopamine, norepinephrine and serotonin in Naples high-excitability rats 1.668
Galactosilated dopamine increases attention without reducing activity in C57BL/6 mice 1.635
Repurposing Pomalidomide as a Neuroprotective Drug: Efficacy in an Alpha-Synuclein-Based Model of Parkinson's Disease 1.616
Prenatal restraint stress differentially modifies basal and stimulated dopamine and noradrenaline release in the nucleus accumbens shell: an 'in vivo' microdialysis study in adolescent and young adult rats. 1.533
CAFFEINE AND ACCUMBENS SHELL DOPAMINE 1.519
Gender specific reduction of hypermotility by sub-chronic methylphenidate or atomoxetine in SH rats, an animal model of ADHD 1.434
Can pioglitazone be potentially useful therapeutically in treating patients with Covid-19? 1.389
PREPUBERAL SUBCHRONIC METHYLPHENIDATE AND ATOMOXETINE INDUCE DIFFERENTIAL LONG TERM EFFECTS ON ADULT BEHAVIOR AND FOREBRAIN DOPAMINE, NOREPINEPHRINE AND SEROTONIN IN NAPLES HIGH EXCITABILITY RATS 1.385
DIFFERENT EFFECTS OF METHYLPHENIDATE AND ATOMOXETINE ON BDNF EXPRESSION IN THE BRAIN OF SPONTANEOULSY HYPERTENSIVE RATS 1.344
Galactosylated dopamine enters into the brain, blocks the mesocorticolimbic system and modulates activity and scanning time in Naples high excitability rats. 1.328
Stimulation of in vivo dopamine transmission in the bed nucleus of stria terminalis by reinforcing drugs 1.286
Cumulative effect of norepinephrine and dopamine carrier blockade on extracellular dopamine increase in the nucleus accumbens shell, bed nucleus of stria terminalis and prefrontal cortex 1.245
CHRONIC TREATMENT WITH METHYLPHENIDATE OR ATOMOXETINE DETERMINES CHANGES OF NORADRENARGIC AND DOPAMINERGIC TRANSMISSION IN THE PREFRONTAL CORTEX OF ADOLESCENT SPONTANEOUS HYPERTENSIVE RATS (SHR): A MICRODIALYSIS STUDY. 1.207
DOPAMINERGIC NEUROTRANSMISSION IN A RAT MODEL OF PRENATAL STRESS 1.154
Function of dopamine in the extrapyramidal and limbic systems 1.121
42) Carboni E, Silvagni A, Barros VG, Di Chiara G. (2006). BASAL AND AMPHETAMINE STIMULATED DOPAMINE AND NORADRENALINE TRANSMISSION IN RAT BRAIN ARE DIFFERENTIALLY AFFECTED BY PRENATAL STRESS: AN IN VIVO MICRODIALYSIS STUDY. 1.100
INCREASE OF EXTRACELLULAR DOPAMINE IN THE PREFRONTAL CORTEX - A TRAIT OF DRUGS WITH ANTIDEPRESSANT POTENTIAL 1.095
BDNF Alterations in Brain Areas and the Neurocircuitry Involved in the Antidepressant Effects of Ketamine in Animal Models, Suggest the Existence of a Primary Circuit of Depression 1.060
Similarities and differences between nicotine and food reward relevance for a theory of reward. 1.033
Homologies and differences in the action of drugs of abuse and a conventional reinforcer (food) on dopamine transmission: an interpretative framework of the mechanism of drug dependence. 1.032
The Intranigral Infusion of Human-Alpha Synuclein Oligomers Induces a Cognitive Impairment in Rats Associated with Changes in Neuronal Firing and Neuroinflammation in the Anterior Cingulate Cortex 1.017
Antidepressants, dose dependently, increase dopamine and norepinephrine extracellular concentration in rat bed nucleus of stria terminalis: a microdialysis study 984
A microdyalisis study of dopamine transmission in the nucleus accumbens shell of SHR rats: a model of attention deficit hyperactivity disorder (ADHD) 974
A MICRODIALYSIS STUDY OF DOPAMINE TRANSMISSION IN THE NUCLEUS ACCUMBENS SHELL OF SHR RATS: A MODEL OF ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) 927
Stimulation of Dopamine Release in the Bed Nucleus of Stria Terminalis. A Trait of Atypical Antipsychotics? 890
Naples high excitability and spontaneously hypertensive model different variants of attention-deficit hyperactivity disorder 878
Dissociation of physical abstinence signs from changes in extracellular dopamine in the nucleus accumbens and in the prefrontal cortex of nicotine dependent rats 841
Differential induction of dyskinesia and neuroinflammation by pulsatile versus continuous L-DOPA delivery in the 6-OHDA model of Parkinson's disease 814
Increase of dialysate dopamine in the bed nucleus of stria terminalis by clozapine and related neuroleptics 811
A challenge dose of amphetamine can be used as a tollo for assessing changes in dopamine and noradrenaline transmission induced by prenatal stress in rats 809
Effect of amphetamine, cocaine and experimental Investigation on dopamine trasmission can provide clues on the mechanism of action of amphetamine and methylphenidate in ADHD 770
Detection of 3H-cimetidine specific binding in rat anterior pituitary 768
6-Hydroxydopamine lesions reduce specific [3H]sulpiride binding in the rat substantia nigra: direct evidence for the existence of nigral D-2 autoreceptors 761
Effect of amphetamine, cocaine and depolarization by high potassium on extracellular dopamine in the nucleus accumbens shell of SHR rats. An in vivo microdyalisis study 758
Effect of Dopamine and Norepinephrine Carrier Blockade on Extracellular Dopamine Release in Rat Brain 758
Experimental investigations on dopamine transmission can provide clues on the mechanism of the therapeutic effect of amphetamine and methylphenidate in ADHD. 751
Role of prefrontal cortex dopamine and noradrenaline circuitry in addiction 736
Dopamine reuptake by norepinephrine neurons: exception or rule? 726
5HT3 antagonists specifically block morphine and nicotine reward 706
Stimulation of dopamine transmission in the dorsal caudate nucleus by pargyline as demonstrated by dopamine and acetylcholine microdialysis and fos immunohistochemistry 697
Dopamine and drug addiction: the nucleus accumbens shell connection 688
Repurposing Ketamine in Depression and Related Disorders: Can This Enigmatic Drug Achieve Success? 675
EFFECT OF PRENATAL STRESS ON BASAL AND STIMULATED DOPAMINE AND NORADRENALINE TRANSMISSION IN RAT BRAIN: IN VIVO MICRODIALYSIS STUDY. 661
Ethanol: lack of stimulation of chloride influì in rat brain synaptoneurosomes 655
CONDITIONED PLACE PREFERENCE: A SIMPLE METHOD FOR INVESTIGATING REINFORCING PROPERTIES IN LABORATORY ANIMALS 646
Dihydropyridines change the uptake of calcium induced by depolarization into primary cultures of cerebellar granule cells. 640
null 638
Characterization of stereospecific binding of 3H-(-) sulpiride, a selective antagonist at dopamine-D2 receptors, in rat CNS. 637
null 637
COMBINED MICRODIALYSIS AND FOS IMMUNOHISTOCHEMISTRY FOR THE ESTIMATION OF DOPAMINE NEUROTRANSMISSION IN THE RAT CAUDATE-PUTAMEN 634
Serotonin release and metabolism in rat cortex as studied by transcerebral dialysis. 627
null 622
null 617
SCH 23390 antagonizes apomorphine- and ergot-induced hypothermia. 600
Characterization of peripheral benzodiazepine type sites in a cultured murine BV-2 microglial cell line 599
null 586
null 583
null 580
Dihydropyridine binding sites regulate calcium influx through specific voltage-sensitive calcium channels in cerebellar granule cells. 575
null 568
null 568
Totale 158.029
Categoria #
all - tutte 219.220
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 219.220


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.882 0 0 0 0 0 0 0 0 0 1.343 1.467 1.072
2021/20227.585 777 486 746 362 481 509 647 489 475 877 717 1.019
2022/202313.596 1.072 1.834 1.208 1.046 1.177 1.179 758 1.094 1.032 1.178 1.395 623
2023/202413.893 606 612 734 830 1.398 2.199 2.279 1.067 631 1.059 1.092 1.386
2024/202530.084 8.438 9.025 4.070 2.666 1.594 1.630 1.320 191 282 272 292 304
2025/20266.985 362 308 918 534 515 911 1.202 508 567 1.160 0 0
Totale 174.342